title: Mass closure of the abdominal wound with delayed absorbable suture in surgery for gynecologic cancer.
abstract: There has been a resurgence of interest recently in the optimal method of closure of the midline abdominal wound. The focus has been on the high-risk patient in particular. The controversy centers on interrupted versus continuous fascial closure and the choice of suture material. For three years on a gynecologic cancer service, running mass closure with delayed absorbable suture (Polyglactin) was used. Two hundred fifty-six patients were evaluable for analysis. The minimum follow-up time was two years. There was no wound dehiscence. Fourteen patients (5.5%) developed incisional hernias. The mass closure technique using delayed absorbable suture was effective in very-high-risk patients.
authors.affiliation: Department of Obstetrics and Gynecology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa 33682-0179.
authors.forename: M S
authors.initials: MS
authors.lastname: Hoffman
authors.forename: A
authors.initials: A
authors.lastname: Villa
authors.forename: W S
authors.initials: WS
authors.lastname: Roberts
authors.forename: J V
authors.initials: JV
authors.lastname: Fiorica
authors.forename: J P
authors.initials: JP
authors.lastname: LaPolla
authors.forename: D P
authors.initials: DP
authors.lastname: Barton
authors.forename: D
authors.initials: D
authors.lastname: Cavanagh
mesh_terms: D005260:Female; D005500:Follow-Up Studies; D005833:Genital Neoplasms, Female / Q000601:surgery*; D006555:Hernia, Ventral / Q000453:epidemiology* / Q000209:etiology; D006801:Humans; D007813:Laparotomy; D008875:Middle Aged; D011098:Polyglactin 910 / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000453:epidemiology* / Q000209:etiology; D013536:Suture Techniques / Q000009:adverse effects*; D013537:Sutures / Q000592:standards*
chemical_list: D011098:Polyglactin 910